Latest news with #di
Glasgow Times
3 days ago
- Entertainment
- Glasgow Times
How does the new Glasgow Southside Paesano compare to the original?
From the moment rumours surrounding the future of the former Di Maggio's on Pollokshaws Road first began to swirl, right up until striking blue signage confirmed beyond doubt that a 'sequel' was on the way, their thoughts have been consumed with little else. It was not a drill. Paesano was coming to Shawlands. READ NEXT: First look inside Glasgow's new Paesano Southside READ NEXT: Paesano opening in Glasgow's Shawlands - what we know so far (Image: Newsquest) A Southsider myself, I have no shame in counting myself among those who scoured the Facebook community pages for updates on opening or snapped pictures of the unit's progress almost daily to share on the family group chat. Of all the wonderful restaurants and bars opened in the area of late, this one felt different. Not just the first major move since the brand was taken over by the DRG group last summer, but a demonstration of confidence that a high-volume operation like this could thrive on this side of the river. The often-regurgitated sentiment of the Southside morphing into the 'new West End' doesn't seem quite as glib now that we too have a Paesano branch to call our own. If you caught our recent Lunch Review of the original city centre restaurant, it will come as no surprise that I am thrilled to welcome the team to the neighbourhood. I love their fuss-free approach to Neapolitan Style pizza and will point-blank refuse to engage with anyone who claims their liberal use of tomato sugo makes for too soggy an affair. It's delicious, affordable and above all, reliable. In over a decade since my first visit, I've never regretted a meal on Miller Street. So, how does the new kid on the block compare? (Image: Newsquest) Well, for one, it's noticeably smaller. Though no less busy, the long shared tables don't stretch quite as far as those in place at the skinny city centre unit, and cleverly positioned mirrors play their part in making the place seem less tightly packed. A difference in layout further means that the Pollokshaws Road restaurant is filled with natural light from a wall of windows looking out towards a busy junction. It feels more open, and therefore less frantic, but an industrial-looking lighting fixture spelling out Paesano with exposed bulbs is a nice nod to the same one used to illuminate their big sister restaurant in town. A scroll of brown paper hung on the far wall showcases today's specials including a 'Carbonara pizza' with guanciale, pecorino and plenty of black pepper, but Paesano purists will be delighted to hear that otherwise the menu is a near carbon copy of the city centre and West End units, with options numbered one to 10. Pictured: The pizza from our Paesano city centre lunch review in February this year (Image: Newsquest) Keen to test the new restaurant under the same conditions as my previous review visit, I order once more the number five of cotto ham with mushrooms, tomato sugo, fior di latte mozzarella, basil and EVOO. There's snacking on sweet and tangy balsamic onions, firm nocellara olives coated in a thin sheen of oil and beautifully fresh slices of vibrant plum tomatoes cutting through creamy burrata to be done while waiting. It's all shared, because instead of my usual solo mission, this week's review mixes business with pleasure as a birthday is marked within my friend group. There are seven of us, but Alessio, our server for the evening, remains unfazed by requests for added chillis or extra dips and sides. He's a jolt of energy on weekday service – and will later make the experience all the more special when catching wind of cause for celebrations in our group, leading the whole restaurant in a spirited rendition of 'Happy Birthday'. Though I've never found fault with the service at Paesano before, none can compare to this team member's show-stealing performance. Pictured: The new Southside Paesano lives up to expectations, and then some (Image: Newsquest) But let's get back to the pizza, shall we? For the sake of this review, I'm glad to notice straight away that there are a few subtle differences between the number five in Shawlands and the one I devoured in the city centre a few months ago. There's still a generous amount of cheese here, but it's not quite the thick blanket of fior di latte that I had tackled the first time round. It feels lighter and better balanced, allowing that salty cotto ham that's just started to curl and crisp at the edges in the intense heat of the oven its chance to shine. The pillowy slow-proved crust, however, is less blackened, robbing the dish of that intense element of charred flavour but still suitably bubbled and blistered. Thankfully, there's the addition of a truffle aioli for dunking, which more than makes up for any peely-wally-ness. Never mind its intended purpose as a dip, I would happily take a teaspoon to this pot of punchy goodness and eat just that on its own as an appetiser. I suspect there's slightly less EVOO glugged across this pizza as a finishing touch, but every Paesano veteran knows that adding your own liberal amounts of the chilli oil which sits alongside seasoning on the tables, is a must anyway. There's a sense of relief as the final bites are finished, knowing now for sure that this new restaurant lives up to expectations. But beyond that, I'm surprised to find myself questioning whether it could even be better than the original? My intention for this week's review was never to play favourites. I only hoped to confirm that standards had carried over to the new home. So, at the risk of sounding biased, I'll simply sign off by saying this is very much the case, and then some. How soon is too soon for the next visit? Price: The number five pizza is priced at £12.50 - worth noting that this is 60p more than what I paid in the city centre branch for the same toppings in our February review. Wait time: Around 25 minutes after ordering. Rating: 5/5. I might anger some by giving this experience 0.5 points more than the city centre restaurant, but the team truly deserves it. Only time will tell if this is opening week magic or not. Paesano Southside is located at 1038-1040 Pollokshaws Road in Glasgow.
Ottawa Citizen
24-04-2025
- Ottawa Citizen
Hum: Caméline in Vieux-Hull indulges a passion for creative pasta
Article content Grilled white asparagus ($23), bolstered with guanciale, grated egg yolk and tarragon aioli, felt like a high-in-umami delicacy. Article content We then shared three of the menu's four pasta dishes. Article content Skewing sweet were the agnolotti filled with roasted beet and house-made ricotta, adorned with stracciatella di bufala (the delicate Italian buffalo-milk cheese), orange honey and poppy seeds ($29). On a plate of toothsome tagliatelle verde ($33), earthy wild mushrooms, black garlic and Calabrian chili were all impactful. Article content Article content Article content Carivnore that I am, I preferred the wild boar tortelletti with gremolata, well-salted kale and fried shallots ($34). But my companions had different favourites among the perfectly al dente pastas. That, of course, is a very good sign. Article content Ordering the three appealing but distinct desserts was a no-brainer. Maple gelato affogato ($12) provided the proper sweet, caffeinated jolt. A well-made slice of white chocolate and blood orange tart ($14) nailed its combination of flavours and textures. A slice of upside down banana cake with brown butter cream and ginger crumble ($15) was super-moist and comforting. Article content Article content Before dinner, cocktails ($11 to $18), such as the mix of mezcal, Aperol, lime juice and pineapple juice that I had, were interesting and well-balanced. Article content The always evolving list of privately imported wines chosen by co-owner Alexandre Régimbal includes about a dozen each of whites and reds. Currently, bottles range from $70 to $105. About 10 wines, including an orange wine and a rosé, are available by the glass. I asked someone who knows much more about wine than I do to survey the list and he called it 'an interesting list of food-friendly wines with a focus on low intervention.' Article content He also remarked that about two-thirds of the bottles are from France or Quebec, and just four are from Italy. I responded that perhaps Caméline thinks of itself as a Québécois restaurant that happens to specialize in pasta, rather than an Italian restaurant per se. Article content Later, when I spoke to Laroche and Régimbal, they said I'd hit the nail on the head. Camelina oil, as we anglophones would say, is a Quebec product, and so the restaurant's name nods to some provincial pride on the part of Laroche, Régimbal, and fellow co-owner Audrey Labelle. Article content Further to that, Laroche offered the example of a cacio e pepe pasta that he's made. His riff on that Italian classic involved Quebec cheese and dune pepper, also native to Quebec. Article content I'd like to try that dish if it ever returns to Caméline's menu. I'd also like to sit on the restaurant's back patio, which will seat about 30 when it opens in a month or so. Article content By then, it will truly be spring. Goodbye, root vegetables. Green asparagus and other seasonal delights will be available. Article content
Yahoo
02-04-2025
- Business
- Yahoo
Advanced Micro Devices (NasdaqGS:AMD) Rises 3% in a Month Amid New EPYC Processors Launch
Advanced Micro Devices launched its 5th Gen EPYC processors, offering a potential uptick in cost-performance ratios and signaling strength in its cloud and embedded markets, which could have supported its share price rise of 3% over the last month. Significant governance changes, such as plans to increase authorized shares, along with altered leadership in AMD's fixed-income offerings, reflect ongoing structural adjustments. Concurrently, the market has faced volatility amid tariff discussions, contrasting with AMD's upward movement despite a broader 3% market drop, suggesting resilience in tech stocks amidst uncertain economic forecasts. Buy, Hold or Sell Advanced Micro Devices? View our complete analysis and fair value estimate and you decide. AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. The last five years have seen Advanced Micro Devices (AMD) achieve a total shareholder return of 116.11%, combining both share price appreciation and dividends. A significant part of this performance can be attributed to AMD's advances in the data center and AI markets, especially with the expansion of its Instinct accelerators and ROCm updates. Additionally, AMD's partnerships, such as those with Oracle and Dell, have bolstered its presence and adoption in cloud and enterprise markets. The development of the 5th Gen EPYC processors introduced groundbreaking improvements in cost-to-performance ratios, further supporting AMD's growth trajectory in competitive segments. Despite challenges, including declines in the Gaming and Embedded segments by 59% and 13% year-over-year respectively, AMD's earnings have surged in the last year. Financially, the company's sales have climbed, as evidenced by Q4 FY2024's US$7.66 billion revenue. However, AMD's share performance over the past year has underperformed both the US Market and the Semiconductor industry. With these dynamics, AMD continues to drive toward capturing more market share in high-performance computing and AI sectors. Get an in-depth perspective on Advanced Micro Devices' performance by reading our balance sheet health report here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:AMD. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Associated Press
13-03-2025
- Health
- Associated Press
Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as 'Dr. Reddy's'), is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the United States. This press release features multimedia. View the full release here: Product Overwrap Description - Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL) (Photo: Business Wire) The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL. Risk Statement: Patients who are administered the mislabeled product will likely experience adverse events. Because the infusion bag is labelled as 500 mg/100 mL but actually contains 1,000 mg/100 mL dose, the patient could receive double the dose of intravenous levetiracetam than intended which could lead to immediate and serious side effects including hypersensitivity reactions, liver injury, hematological toxicity, somnolence, fatigue, dizziness, coordination difficulties, agitation, aggression, depressed level of consciousness, respiratory depression, and coma. Patients receiving high doses of levetiracetam by rapid intravenous infusion for the treatment of status epilepticus would be most at risk for severe adverse events. Dr. Reddy's has not received any reports of adverse events related to this recall. Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) and Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL (5mg/mL) are both indicated for adjunct therapy in adults (≥16 years of age) with the following seizure types when oral administration is temporarily not feasible: - Partial onset seizures - Myoclonic seizures in patients with juvenile myoclonic epilepsy - Primary generalized tonic-clonic seizures Each product is packaged in single-dose infusion bags with an aluminum overwrap, 10 single-dose bags packed in a carton. Identification information such as lot number, expiration date and NDC is presented in the table below. The batch was distributed nationwide between November 4, 2024, and November 6, 2024, to wholesalers. DESCRIPTION OF MISLABELLED BAGS BEING RECALLED: 43598-635-52 Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag. A1540076 08/2026 43598-636-52 Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL single-dose bag A1540076 08/2026 DESCRIPTION OF CARTON BEING RECALLED: Dr. Reddy's Laboratories, Inc is notifying its distributors and customers to arrange for return of any recalled product. Wholesalers, distributors, hospitals, and pharmacies with an existing inventory of the lot being recalled should stop use and distribution and quarantine the product immediately for return/replacement of all recalled products. Wholesalers, distributors, and pharmacies that have further distributed the recalled product should notify any accounts or additional locations which may have received the recalled product from them. For instructions on returning product or additional assistance, call Inmar at 1-877-645-1584 between the hours of 9 a.m. to 5 p.m. ET, Monday through Friday. Consumers with questions regarding this recall can contact Dr. Reddy's Medical Information Call Center at 1-888-375-3784 (1-888-DRL-DRUG) between the hours of 8 a.m. to 8 p.m. ET, Monday through Friday. Consumers should contact their healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality concerns experienced with the use of this product may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report online at Regular Mail or Fax: Download form at or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. This recall is being executed with the knowledge of the U.S. Food and Drug Administration. RDY-0325-782 About Dr. Reddy's: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of 'Good Health Can't Wait', we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words 'may', 'will', 'should', 'expects', 'plans', 'intends', 'anticipates', 'believes', 'estimates', 'predicts', 'potential', or 'continue' and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers', products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the 'Risk Factors' and 'Forward-Looking Statements' sections of our Annual Report on Form 20-F for the year ended March 31, 2024. The company assumes no obligation to update any information contained herein. [email protected] RELATIONS USHA IYER [email protected] SOURCE: Dr. Reddy's Laboratories Ltd. Copyright Business Wire 2025. PUB: 03/13/2025 10:40 AM/DISC: 03/13/2025 10:39 AM
Telegraph
08-03-2025
- Entertainment
- Telegraph
Torture and starvation: The horrors of being a Hamas hostage
Dalia Cusnir takes a moment to compose herself in the relative peace of Tel Aviv's central library. Outside, in what has become known as Hostages Square, a large crowd chants a mixture of angry slogans and mournful songs as the last hours of Israel's ceasefire deal with Hamas slip away. Inside, Dalia prepares to answer that simplest yet hardest of questions: how are you? Tonight it's particularly hard. Less than two hours ago, Hamas released a propaganda video shot in the tunnels of Gaza showing her two beloved brothers-in-law, Iair and Eitan Horn. Iair, 46, was released on Feb 15, but Eitan, 38, never made it onto the list of hostages to get out under the first phase of the deal. Set to emotional music and with liberal use of reverberative echo, the video lingers on the brothers as they hug and sob uncontrollably in the moments before they were torn apart. 'Do you want me to leave my little brother to die,' cries a desperate-looking Iair down the camera, presumably directed at the Israeli government, presumably on his captors' orders. Eitan, for his part, says: 'Sometimes I am fine and not fine. But here,' he adds, pointing to his head, 'I am not fine,' before breaking down in tears again. Dalia lets out a long breath. The family had known the video would come. But still, 'It was a big shock,' she says. 'It's a sign that things are getting too late. It's like a desperate person is drowning and with his last voice is calling on us, but we cannot help.' Naturally on the stocky side, Eitan does not look quite as gaunt as some of his fellow hostages. But it is the blotchy spots on his arm that causes Dalia the greatest concern. For years now, the community organiser has suffered from a rare and serious skin condition that requires daily medication to keep under control. Without it, he could develop sepsis at any minute, which would most likely be fatal. 'The video showed his arms full of wounds. He should be taking antibiotics, proper hygiene and avoiding humid places, and we know he's not getting any of those,' says Dalia. 'We all saw the images on Oct 7 2023. Hamas slaughtered, they burned, they abducted, they raped. It's the same people who are holding him.' 'Torture' is a word that has increasingly entered Israeli public discourse since the latest batch of hostage releases began in mid-January. Mostly, the hostages have kept their counsel, with hints and suggestions of what they endured emerging via family members such as Dalia. Despite this, we are learning enough to know that the 'torture' took many forms, denial of basic healthcare, including for those wounded in the massacre of Oct 7, being one of them. Eliya Cohen, the 26-year-old who was freed late last month, endured crude surgery to dig a number of bullets out of his leg without anaesthetic, according to reports. Alon Ohel, who was chained to Mr Cohen for much of the time, went into captivity with an eye wound which, his family believes, has never been properly treated. Like Eitan, he did not make it onto the first-phase hostage release list. As things stand, there is no second phase. According to Dalia, Iair Horn is still 'not seeing well', despite never having needed glasses before, a hint that his eyesight might be permanently damaged as a result of (nearly) 500 days of poor light. She and others have talked about their loved ones 'learning to walk again', having been cramped for so many months. Then there were the beatings. In an interview last week that shook Israel's political establishment to its foundations, recently released hostage Eli Sharabi described suffering broken ribs from the attacks, which he said were closely linked to comments made by hard-Right Israeli ministers who endorsed harsh treatment of Palestinian prisoners. 'We knew they were watching it [the news],' he told Channel 12. 'Every responsible utterance, the first ones to suffer from it are us.' Mr Sharabi, who only learnt that his wife and daughters had been murdered upon his release, directed specific criticism at Itamar Ben-Gvir, the former national security minister, for his comments. The ultra-nationalist refused to apologise. This week, he said he was proud of remarks and accused the former hostage of 'echoing Hamas propaganda'. To what extent was torture in the traditional sense – the deliberate imposition of pain – widespread, and what forms did it take? Sagui Dekel-Chen, for example, still has scars from wounds inflicted during an interrogation by Hamas, his family has suggested. But, for the most part, we simply don't know, because those who may have suffered it are unwilling to discuss it publicly, or even, in some cases, behind closed doors. 'He's not talking about specific torture,' says Dalia of Iair. 'We've been told not to ask about it and to respect that. 'He still has Eitan there. He believes that every incorrect word might be used to damage Eitan.' Despite the murkiness around this question, we are learning from multiple released hostages that the mere method of physical restraint was often torture enough. Eyal Kalderon, the brother of Ofer, who was released on Feb 1, spoke to The Telegraph at the protest in Tel Aviv on March 1. 'In the beginning he was held by both legs and cuffs in a cage,' he said. 'It was a very tiny cage and he shared it with one other, Yarden [Bibas, husband and father to the murdered Shiri, Ariel and Kfir].' Mr Sharabi described in his TV interview the excruciating pain of the restraint methods initially used by Hamas. 'During the first three days my hands are tied behind my back, my legs are tied with ropes that tear into your flesh,' he recalled. 'I remember not being able to fall asleep because of the pain.' Prof Hagai Levine, the medical adviser to the Hostages Family Forum, said: 'We know that they were locked, shackled, which is very traumatic for people. 'We know some were cuffed upside down. From the legs down. Any kind of torture that you can imagine. It's literally hell.' Excruciating as this sounds, it seems that the most prolific form of 'torture' – not to mention the easiest for the Hamas captors to inflict – was the pain caused by starvation. Indeed, Mr Sharabi said that, for him, it was worse than the broken ribs. For months, a small bowl of pasta or a piece of pitta bread was the norm – perhaps 200-300 calories a day, a fraction of what an adult requires to stay healthy. The tunnels echoed to the sounds of hostages moaning in pain from the hunger. Even obtaining an extra dried date from the guards became a major victory as the months dragged on. It was the shockingly emaciated state of Mr Sharabi, Ohad Ben Ami and Or Levy as they were released on Feb 8 that first woke Israel up to the full horror of the hostages' starvation. But, from the testimony of others, it seems that this was a rare PR blip from Hamas, which generally took care to feed those slated for release more, to give a better impression to the outside world. Speaking of his brother again, Mr Kalderon said: 'In the month before [his release] they started to give him more food. And so he went out in a bit better shape.' Boredom was a torture all of its own, and prompted a range of coping mechanisms. 'Ofer said he didn't realise how many songs he knew the words to,' said Mr Kalderon. 'He sang so many songs to Yarden. It helped keep his mind positive.' Others formed fiercely close and protective friendships. Mr Sharabi talked about swiftly 'adopting' the younger Alon Ohel, and constantly being together for long periods meant he knew 'everything about him and his family'. But, again, these comforts came with a sting in the tail. When Mr Ohel learnt that his friend was to be released without him, it prompted panic, 'a moment of hysteria'. Despite being happy that the older man was being released, it took him 15 minutes to calm down. Viki Cohen, whose now 20-year-old son was the only survivor from an Israeli tank crew that was overrun on Oct 7, said she had heard from released hostages that the young man 'talked a lot about his family', while in captivity. 'He missed us very much and believes we will do everything we can to bring him back.' For many hostages abducted from the melee of Oct 7, its the torture of not knowing if their loved ones were alive or dead. Mr Sharabi, we now know, went 15 months without knowing that his close family were all dead. Yarden Bibas, similarly, only found out about the appalling fate of his wife and two children after he was released and their bodies were returned by Hamas. It appears that Hamas also used ambiguity over whether individual hostages would be released as a form of abuse. Prof Levine said: 'They were told you are going to be released and they are not released, so they don't know what to believe. 'They were told that family members were murdered or not murdered – they don't know.' Overall, returned hostages have shared a feeling best summed up by Ofer Kalderon. 'He described it as being buried alive,' said his brother. 'He didn't see the light for all of this period. 'Apart from terrorists, he didn't see anyone apart from rats or spiders.' Back in Israel, the torment continues. How a person even begins to rehabilitate after such experiences is a massive question. But, as loved ones are finding out, some of the released hostages are not prepared even to start while their friends remain in the tunnels. 'Iair is not willing to start rehabilitation,' said Dalia. 'He says 'I'm going to start, but I'll do it when Eitan and all the rest are back'. 'He keeps saying, 'they have no time, they have no time – trust me, I've been there'.' Eyal Kalderon says something very similar. 'He [Ofer] cannot start his process of healing until everybody is out,' he said. Treading a delicate path Adding to the anguish of the newly released is the dilemma of how best to campaign to get the others out: to reveal to the world the full horror of the conditions; or to keep quiet for fear of antagonising Hamas and making things worse for those still captive? Most, it seems, are treading a delicate path, but leaning towards the latter. That is why Mr Sharabi's intervention last week was so momentous – it even appeared to rattle Benjamin Netanyahu sufficiently to offer an extremely rare apology. Those who believe in a more muscular approach hope that it will be a turning point, that others will come forward and recount their ordeals in detail, creating a wave of disgust strong enough to force the government into accepting the strategic compromises that would come with a proper second-phase agreement. Last week, Iair Horn, Mr Sharabi and others visited Donald Trump in Washington for a meeting in the Oval office. The meeting appeared to move the US president so much that within hours he had issued a warning to Hamas stating that this was its last chance to release the remaining hostages: ''Shalom Hamas' means Hello and Goodbye.' Many in Israel hoped the visit would prevent the drift back to all-out war that could spell disaster for the remaining 24 living hostages. At the very least, it may have provided a smidgen of distraction for Iair. 'He says 'you think I'm here, you look at me, but I'm not',' his sister said. 'My soul, my body and my mind is in Gaza. Please release me.'
